Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort-term InvestmentsWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Liabilities and Shareholders Equity: 2020-2024

Historic Liabilities and Shareholders Equity for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to $121.3 million.

  • Burning Rock Biotech's Liabilities and Shareholders Equity fell 18.70% to $114.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $468.3 million, marking a year-over-year decrease of 16.97%. This contributed to the annual value of $121.3 million for FY2024, which is 17.20% down from last year.
  • Per Burning Rock Biotech's latest filing, its Liabilities and Shareholders Equity stood at $121.3 million for FY2024, which was down 17.20% from $146.5 million recorded in FY2023.
  • Burning Rock Biotech's Liabilities and Shareholders Equity's 5-year high stood at $408.1 million during FY2020, with a 5-year trough of $121.3 million in FY2024.
  • Its 3-year average for Liabilities and Shareholders Equity is $166.0 million, with a median of $146.5 million in 2023.
  • In the last 5 years, Burning Rock Biotech's Liabilities and Shareholders Equity grew by 12.39% in 2021 and then tumbled by 36.36% in 2023.
  • Over the past 5 years, Burning Rock Biotech's Liabilities and Shareholders Equity (MRY) stood at $408.1 million in 2020, then fell by 12.39% to $357.6 million in 2021, then plummeted by 35.63% to $230.2 million in 2022, then plummeted by 36.36% to $146.5 million in 2023, then decreased by 17.20% to $121.3 million in 2024.
  • Its last three reported values are $121.3 million in FY2024, $146.5 million for FY2023, and $230.2 million during FY2022.